The silent hemoglobin α chain variant Hb Riccarton [α51(CE9)Gly→Ser] may affect HbA1c determination on the HLC-723 G7 analyzer

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 6, 2008, Pages 827-830

  Van Den Ouweland, Johannes M W ^a   Van Daal, Henny ^a   Klaassen, Corné H ^a   Van Aarssen, Yvonne ^a   Harteveld, Cornelis L ^b   Giordano, Piero C ^b  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

thalassemia; Diabetes mellitus; Glycated hemoglobin; Hemoglobin A1c; Hemoglobin variants; Ion exchange HPLC

Indexed keywords

ALPHA GLOBIN; GLYCINE; HEMOGLOBIN A1C; HEMOGLOBIN RICCARTON; HEMOGLOBIN VARIANT; SERINE;

AGED; ALPHA THALASSEMIA; ANALYTICAL ERROR; ARTICLE; ARTIFACT; BLOOD CHEMISTRY; CASE REPORT; DIABETES MELLITUS; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL;

AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS, ABNORMAL; HUMANS; MALE; REPRODUCIBILITY OF RESULTS;

EID: 44949101187     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.169     Document Type: Article

References (13)

1. American Diabetes Association. Standards of medical care of diabetes. Diabetes Care 2007;30:S4-41.
2. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006;49:1711-21.
3. Bry L, Chen PC, Sacks DB. Effects of haemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-63.
4. Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat 2007;28:206-15.
5. Terreni A, Paleari R, Caldini A, Ognibene A, Mosca A, Messeri G. Evaluation of the analytic performances of the new HPLC system HLC-723 G7 for the measurement of hemoglobin A1c. Clin Biochem 2003;36:607-10.
6. Gremmels H-D, Richter A, Watzke I. Evaluation of the haemoglobin A1c-analyzer TOSOH HLC-723 G7. Clin Lab 2003;49:243-50.
7. Thomas LB, Agosti SJ, Man MA, Mastorides SM. Screening for hemoglobinopathies during routine hemoglobin A1c testing using the Tosoh G7 glycohemoglobin analyzer. Ann Clin Lab Sci 2007;37:251-5.
8. Schnedl WJ, Lahousen T, Lang T, Lipp RW, Yonehara S, Fukunaga S, et al. Determination of glycated hemoglobin in clinically silent hemoglobin variants. Diabetes Metab Res Rev 2004;20:460-5.
9. Harteveld CL, Versteegh FG, van Leer EH, Starreveld JS, Kok PJ, van Rooijen-Nijdam I, et al. Hb St. Jozef, A Val→Leu N-terminal mutation leading to retention of the methionine, and partial acetylation found in the globin gene in Cis with a -alpha3.7 thalassemia deletion. Hemoglobin 2007;31:313-23.
10. Brennan SO, Chan T, Obele M, George PM. Hb Riccarton [α51(CE9) Gly→Ser]: a variant arising from a novel mutation in the α1 gene. Hemoglobin 2005;29:61-4.
11. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of α-thalassemia deletions and α-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 2000;108:295-9.
12. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood 2000;95:360-2.
13. Roberts WL. Hemoglobin constant spring can interfere with glycated haemoglobin measurements by boronate affinity chromatography. Clin Chem 2007;53:142-3.